Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
AbbVie
Age
15–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
\- All participants treated with RINVOQ.
You may not be if
\- Participants not taking RINVOQ.
Clareo Health | Study To Assess Frequency Of Serious Infections In Clinical Practice In Japan For Adult Participants With Rheumatoid Arthritis Receiving Oral RINVOQ Tablets
